Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer

Omar Elakad1, Anna-Maria Lois1, Katja Schmitz1

  • 1Institute of Pathology, University Medical Center, Göttingen, Germany.

Cancer Medicine
|March 25, 2020
PubMed
Abstract

Insights

Fibroblast growth factor receptor 1 (FGFR1) amplification and expression do not impact lung cancer patient survival. Current patient selection for FGFR1 inhibitors may need reconsideration based on these findings.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Targeting fibroblast growth factor receptor 1 (FGFR1) shows promise for squamous cell lung cancer (SQCLC).
  • Current treatment decisions rely on FGFR1 gene amplification, but durable responses are limited.
  • Previous research on FGFR1's prognostic impact in lung cancer yields conflicting results.

Purpose of the Study:

  • To investigate the prevalence and correlation of FGFR1 gene amplification and protein expression in lung cancer.
  • To determine the impact of FGFR1 amplification and expression on overall survival.
  • To evaluate the relationship between FGFR1 amplification, expression, and clinicopathological characteristics.

Main Methods:

  • Analyzed FGFR1 gene amplification using fluorescence in situ hybridization in 208 SQCLC and 45 small cell lung cancers (SCLC).
  • Assessed FGFR1 protein expression via immunohistochemistry in SQCLC, SCLC, and 121 pulmonary adenocarcinomas (ACs).
  • Correlated amplification and expression with clinicopathological features and overall survival.

Main Results:

  • FGFR1 amplification occurred in 23% of SQCLC and 8% of SCLC, correlating with male patients but not survival.
  • Strong FGFR1 expression was observed in 9% of SQCLC, 35% of ACs, and 4% of SCLCs, correlating with females and absence of lymph node metastasis in SQCLC, but not survival.
  • No significant correlation was found between FGFR1 gene amplification and protein expression.

Conclusions:

  • FGFR1 gene amplification does not correlate with its protein expression in lung cancer.
  • Neither FGFR1 amplification nor protein expression appears to influence patient prognosis.
  • Patient selection for FGFR1 inhibitors warrants re-evaluation.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...